Akoya Biosciences CEO Brian McKelligon's 2022 pay jumps 35% to $3M
Akoya Biosciences reports 2022 executive compensation
By ExecPay News
Published: April 20, 2023
Akoya Biosciences reported fiscal year 2022 executive compensation information on April 20, 2023.
In 2022, three executives at Akoya Biosciences received on average a compensation package of $1.8M, a 9% decrease compared to previous year.
Average pay of disclosed executives at Akoya Biosciences
Brian McKelligon, Chief Executive Officer, received $3M in total, which increased by 35% compared to 2021. 31% of McKelligon's compensation, or $951K, was in option awards. McKelligon also received $630K in non-equity incentive plan, $518K in salary, $950K in stock awards, as well as $443 in other compensation.
Ehab El-Gabry, Chief Medical Officer, received a compensation package of $1.3M. 57% of the compensation package, or $719K, was in option awards.
Marilee Moy, Chief People Officer, earned $1.1M in 2022.
Related executives
You may also like
Source: SEC filing on April 20, 2023.